Mira Pharmaceuticals Inc (NASDAQ: MIRA) kicked off on Monday, down -7.77% from the previous trading day, before settling in for the closing price of $1.93. Over the past 52 weeks, MIRA has traded in a range of $0.51-$6.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 21.35%. With a float of $9.52 million, this company’s outstanding shares have now reached $14.78 million.
In an organization with 3 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mira Pharmaceuticals Inc (MIRA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Mira Pharmaceuticals Inc is 35.60%, while institutional ownership is 4.82%. The most recent insider transaction that took place on May 21 ’24, was worth 8,176. In this transaction Chief Executive Officer of this company bought 8,700 shares at a rate of $0.94, taking the stock ownership to the 382,200 shares. Before that another transaction happened on Dec 04 ’23, when Company’s 10% Owner sold 61,331 for $3.98, making the entire transaction worth $244,097. This insider now owns 723,062 shares in total.
Mira Pharmaceuticals Inc (MIRA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 21.35% per share during the next fiscal year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
Take a look at Mira Pharmaceuticals Inc’s (MIRA) current performance indicators. Last quarter, stock had a quick ratio of 3.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was inferior than the volume of 2.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.59%. Additionally, its Average True Range was 0.40.
During the past 100 days, Mira Pharmaceuticals Inc’s (MIRA) raw stochastic average was set at 28.22%, which indicates a significant increase from 5.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 105.34% in the past 14 days, which was lower than the 350.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3845, while its 200-day Moving Average is $1.3200. However, in the short run, Mira Pharmaceuticals Inc’s stock first resistance to watch stands at $1.8859. Second resistance stands at $1.9917. The third major resistance level sits at $2.0747. If the price goes on to break the first support level at $1.6971, it is likely to go to the next support level at $1.6141. The third support level lies at $1.5083 if the price breaches the second support level.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Key Stats
The company with the Market Capitalisation of 26.31 million has total of 14,781K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -11,980 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -1,720 K.
